Core Viewpoint - Monte Rosa Therapeutics, Inc. has announced a public offering of 11,125,000 shares of common stock priced at $24.00 per share, along with pre-funded warrants for 1,375,000 shares at $23.9999 each, aiming to raise approximately $300 million in gross proceeds before expenses [1]. Group 1: Offering Details - The public offering includes a 30-day option for underwriters to purchase an additional 1,875,000 shares at the public offering price [1]. - The offering is expected to close on or about January 12, 2026, pending customary closing conditions [1]. - The offering is conducted under an effective shelf registration statement filed with the SEC on March 20, 2025, and declared effective on March 31, 2025 [3]. Group 2: Underwriters - Jefferies, TD Cowen, and Piper Sandler are acting as joint book-running managers for the offering [2]. - Wedbush PacGrow and LifeSci Capital are serving as passive bookrunners [2]. Group 3: Company Overview - Monte Rosa Therapeutics is a clinical-stage biotechnology company focused on developing molecular glue degrader (MGD) medicines for serious diseases [6]. - The company utilizes its QuEEN™ discovery engine, which integrates AI-guided chemistry and structural biology, to design MGDs with high selectivity [6]. - Monte Rosa has a leading pipeline of MGDs targeting autoimmune, inflammatory diseases, and oncology, with three programs currently in clinical stages [6].

Core Viewpoint - Soren Acquisition Corp. successfully closed its initial public offering (IPO) of 25,300,000 units, generating gross proceeds of $253 million, with a focus on pursuing business combinations in the healthcare industry [1][3]. Group 1: IPO Details - The IPO was priced at $10.00 per unit, resulting in gross proceeds of $253 million [1]. - The units began trading on January 7, 2026, on the Nasdaq under the ticker symbol "SORNU" [2]. - Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at an exercise price of $11.50 [2]. Group 2: Company Structure and Management - Soren Acquisition Corp. is a blank check company aimed at merging or acquiring businesses, particularly in the healthcare sector [3]. - The management team includes CEO Arghavan Di Rezze and CFO Jamie Weber, along with other board members [4]. Group 3: Legal and Advisory Support - BTIG, LLC acted as the sole book-running manager for the offering, while Reed Smith LLP served as legal counsel to the company [5]. - Walkers (Cayman) LLP provided legal counsel in the Cayman Islands, and Ellenoff Grossman & Schole LLP represented the underwriter [5].

Core Insights - SALI Tools has launched the "SALI & UKAZ Joint Public Welfare Fund" to support community welfare projects in Ethiopia, marking a significant step in its corporate social responsibility efforts [1][2] - The fund will be financed by a portion of SALI Tools' annual revenue, emphasizing a long-term commitment to community development rather than a one-time donation [2] - This initiative aligns with SALI Tools' historical focus on philanthropy and community support, reinforcing its values and commitment to social responsibility [2][5] Company Overview - SALI Tools is a leading global brand in professional tool solutions, known for its high-quality and diverse product offerings [7] - The company has established a strong brand presence across multiple global markets while maintaining a commitment to corporate social responsibility [7] - SALI Tools believes that the long-term value of a business lies in creating shared value for employees, customers, and society [7] Partnership Details - UKAZ is a key business partner for SALI Tools in Ethiopia and the East African region, focusing on local sustainable development [6] - The joint fund will enable UKAZ to implement community welfare projects more effectively, addressing localized needs [6] - SALI Tools and UKAZ have a history of collaboration, including a supplies donation drive organized in November 2019 [3][4]

Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year FacilityNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of US$35.1 million on Ryoncil® (remestemcel-L-rknd) sales for the quarter ended December 31, 2025.1 This represents a 60% increase on the prior quarter ended September 30, 2025. Ryoncil® is the first mesenchymal stromal cell (MSC) product approv ...

Core Viewpoint - California Water Service Group has agreed to purchase the remaining membership interests of BVRT Utility Holding Company, becoming the sole owner of its water and wastewater utilities in the Austin-San Antonio corridor [1] Group 1: Acquisition Details - The acquisition is subject to customary terms and conditions, including approval from the Public Utilities Commission of Texas and the Group Board [2] - The acquisition will enhance California Water Service Group's investment and operations in Texas, allowing for better integration of the BVRT team [5] Group 2: Expansion and Infrastructure - BVRT has been expanding its Texas footprint by building and enhancing water and wastewater infrastructure [1] - Camino Real Utility Company, a BVRT subsidiary, has received a water certificate to serve future customer connections in a 230-acre area in Caldwell County [3] - Camino Real currently provides wastewater service to 270 customers and has plans to extend its sewer main to serve a new development expected to include up to 5,000 dwelling units by 2036 [4] Group 3: Company Overview - California Water Service Group operates regulated utilities across multiple states, providing water and wastewater services to over 2.1 million people [6]

Core Viewpoint - Semilux International Ltd. has received a deficiency notice from Nasdaq regarding its Market Value of Listed Securities, which fell below the required minimum of $35 million, impacting its compliance status for continued listing on the Nasdaq Global Market [1][2]. Group 1: MVLS Deficiency Notice - The MVLS Deficiency Notice indicates that from November 13, 2025, to December 30, 2025, the Company's MVLS was below the $35 million threshold required for Nasdaq listing [1]. - The notice does not immediately affect the trading of the Company's ordinary shares, which continue to trade under the symbol "SELX" [2]. Group 2: Compliance Timeline - The Company has until June 29, 2026, to regain compliance with the MVLS Requirement, as per Nasdaq Listing Rule 5810(c)(3)(C) [2]. - To regain compliance, the Company's MVLS must close at $35 million or more for at least ten consecutive business days during the compliance period [2]. Group 3: Potential Delisting - If compliance is not achieved by the Compliance Date, Nasdaq will issue a notice regarding potential delisting, which the Company can appeal [3]. - There is no guarantee that any appeal against a delisting determination would be successful [3]. Group 4: Company Actions - The Company plans to actively monitor its MVLS and will take reasonable measures to regain compliance with the MVLS Requirement [4]. - Despite the Company's efforts to maintain its listing, there is no assurance that it will successfully regain or maintain compliance with Nasdaq's continued listing standards [4].

Core Viewpoint - Lafayette Digital Acquisition Corp. I has announced the pricing of its initial public offering (IPO) of 25,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of a redeemable warrant [1] Group 1: IPO Details - The IPO consists of 25,000,000 units priced at $10.00 each, with each unit including one Class A ordinary share and one-fourth of a redeemable warrant [1] - Each whole warrant can be exercised 30 days after the completion of the initial business combination, allowing the holder to purchase one Class A ordinary share at $11.50 per share [1] - The units are expected to begin trading on Nasdaq under the ticker symbol "ZKPU" starting January 9, 2026 [1] Group 2: Underwriting and Closing - BTIG, LLC is acting as the sole book-running manager for the offering [2] - The underwriter has a 45-day option to purchase up to an additional 3,750,000 units at the initial public offering price to cover over-allotments [2] - The offering is expected to close on January 12, 2026, subject to customary closing conditions [2] Group 3: Company Overview - Lafayette Digital Acquisition Corp. I is a special purpose acquisition company (SPAC) formed to effect a merger or similar business combination with one or more businesses, primarily focusing on the technology industry [5] - The management team is led by Samuel A. Jernigan IV, who serves as the Chief Executive Officer and Chairman of the Board of Directors [5]

Core Viewpoint - Texas Capital Bancshares, Inc. is set to release its financial results for the full year and fourth quarter of 2025 on January 22, 2026, before market opening [1] Group 1: Financial Results Announcement - The company will host a conference call and webcast to discuss the operating results on January 22, 2026, at 9:00 a.m. EDT [1] - Participants can pre-register for the call to receive a unique PIN for immediate access [1] - An alternative method to join the call is available by calling 833.470.1428 with the access code 907780 [2] Group 2: Webcast and Presentation - The live webcast of the conference call can be accessed through a specific link [2] - Presentation slides related to the financial results will be available on the company's investor website [2] - A replay of the webcast will be available one hour after the call concludes [2] Group 3: Company Overview - Texas Capital Bancshares, Inc. is the parent company of Texas Capital Bank and is a member of the Russell 2000 Index and the S&P MidCap 400 [3] - The company offers a full range of financial services, including commercial banking, consumer banking, investment banking, and wealth management [3] - Founded in 1998 and headquartered in Dallas, Texas Capital has established a nationwide client network [3]

Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026 SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys, GSK, and TESARO, Inc. (“Tesaro”) regarding their Collaboration and Exclusive Licen ...

Core Insights - Algoma Steel Group Inc. provided guidance for its quarter ended December 31, 2025, indicating total steel shipments expected to be between 375,000 to 380,000 tons and Adjusted EBITDA anticipated to be in the range of negative $95 million to negative $105 million [2][3] Group 1: Financial Performance - Total steel shipments for the quarter are projected to be between 375,000 to 380,000 tons [2] - Adjusted EBITDA is expected to be between negative $95 million to negative $105 million [2] Group 2: Operational Developments - The fourth-quarter results reflect the ongoing impact of steel tariffs and the wind-down of blast furnace operations, which are expected to conclude shortly [3] - The first unit of the Electric Arc Furnace (EAF) project is now operating six days a week, with the second unit on schedule [3] - The transition to EAF steelmaking is aligned with Canada's national interest, aiming to strengthen domestic steelmaking capacity and support critical infrastructure [3] Group 3: Sustainability Initiatives - The transition to EAF steelmaking is one of the largest industrial decarbonization initiatives in North America, expected to reduce carbon emissions by approximately 70% once fully transitioned [5] - Algoma is introducing Volta™, a brand for all steel produced through EAF technology, which promises lower emissions while maintaining performance [6] - The company continues to invest in its people, processes, and technologies to enhance domestic supply chains and produce responsible Canadian-made steel [6]